Ocular Morbidity Among Children With Protein Energy Malnutrition in Northwest Nigeria
Asimau Eivovo Idris Zubairu1, Kehinde Kabir Oladigbolu1, Elsie Samaila1
1Department of Ophthalmology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.
Insights
Protein energy malnutrition (PEM) in Nigerian children significantly increases the risk of ocular problems, including vision impairment. Early detection and intervention are crucial to prevent irreversible blindness from PEM.
Area of Science:
- Ophthalmology
- Pediatrics
- Public Health
Background:
- Protein energy malnutrition (PEM) is a significant health issue in Nigeria, particularly in the northern regions.
- Previous studies have linked PEM to ocular morbidity and blindness, but recent data is scarce.
- This study aims to provide current insights into the ocular manifestations of PEM in Northern Nigeria.
Purpose of the Study:
- To assess the prevalence and types of ocular abnormalities in children with PEM compared to well-nourished children.
- To establish a contemporary baseline for ocular complications associated with PEM in Northern Nigeria.
- To highlight the link between PEM and visual impairment.
Main Methods:
- A comparative, cross-sectional study involving 400 children aged 6-59 months (200 with PEM, 200 without).
- Detailed ocular examinations including visual acuity, adnexae, anterior, and posterior segments.
- Data collected via structured proforma and analyzed using SPSS and WinPepi software.
Main Results:
- Children with PEM exhibited significantly higher rates of abnormal ocular findings (46.5%) compared to the non-malnourished group (24%).
- Common findings in the PEM group included infective conjunctivitis (35.5%), lid edema (11%), xerophthalmia (6%), and visual impairment (3%).
- PEM was associated with an odds ratio of 2.91 for ocular abnormalities.
Conclusions:
- Protein energy malnutrition continues to be a significant cause of ocular morbidity in Nigerian children.
- PEM can lead to severe eye conditions, including xerophthalmia and visual impairment.
- There is a potential for progression to irreversible blindness if PEM-related ocular complications are not addressed.
Background:
Protein energy malnutrition (PEM) remains a major health challenge in Nigeria, especially Northern Nigeria. Its association with ocular morbidity and irreversible blindness has been previously documented. There are however limited recent literature on these ocular manifestations, which may have evolved over the years. This study is thus relevant to establish a current baseline for the ocular manifestations associated with PEM in Northern Nigeria.
Materials And Methods:
This was a comparative, cross-sectional study. The sample size was 400 children; 200 with PEM, and 200 without PEM. Consenting parents with children between 6 - 59 months of age diagnosed with PEM, and those without PEM were recruited. Sociodemographic characteristics, general and ocular history were documented. A detailed ocular examination which included visual acuity assessment, examination of ocular adnexae, as well as the anterior and posterior segment of the eyes were done. Data was collected in a structured proforma, and analysed with the SPSS version 21, and Windows WinPepi softwares.
Results:
Abnormal ocular findings were significantly higher in the PEM group compared to the non-malnourished group [46.5% vs 24%, OR = 2.910 (1.891, 4.477), p = < 0.001]. The predominant ocular examination findings in the PEM and non-malnourished groups were infective conjunctivitis (35.5% vs 17%), lid oedema (11% vs 0%), signs of xerophthalmia (6% vs 0%) and visual impairment (3% vs 0%).
Conclusion:
PEM is still complicated by varying severity of ocular morbidity, with the potential of progression to irreversible blindness.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Nephrotic Syndrome I : Introduction
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview


